{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:41:08Z","timestamp":1788392468784,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research and Innovation Director (RID) office of Institute of Health, Jimma University","award":["Mega Research Fund Scheme (2022-2025)"],"award-info":[{"award-number":["Mega Research Fund Scheme (2022-2025)"]}]},{"name":"Research and Innovation Director (RID) office of Institute of Health, Jimma University","award":["Mega Research Fund Scheme (2022-2025)"],"award-info":[{"award-number":["Mega Research Fund Scheme (2022-2025)"]}]},{"name":"Research and Innovation Director (RID) office of Institute of Health, Jimma University","award":["Mega Research Fund Scheme (2022-2025)"],"award-info":[{"award-number":["Mega Research Fund Scheme (2022-2025)"]}]},{"name":"Research and Innovation Director (RID) office of Institute of Health, Jimma University","award":["Mega Research Fund Scheme (2022-2025)"],"award-info":[{"award-number":["Mega Research Fund Scheme (2022-2025)"]}]},{"name":"Research and Innovation Director (RID) office of Institute of Health, Jimma University","award":["Mega Research Fund Scheme (2022-2025)"],"award-info":[{"award-number":["Mega Research Fund Scheme (2022-2025)"]}]},{"name":"Research and Innovation Director (RID) office of Institute of Health, Jimma University","award":["Mega Research Fund Scheme (2022-2025)"],"award-info":[{"award-number":["Mega Research Fund Scheme (2022-2025)"]}]},{"name":"Research and Innovation Director (RID) office of Institute of Health, Jimma University","award":["Mega Research Fund Scheme (2022-2025)"],"award-info":[{"award-number":["Mega Research Fund Scheme (2022-2025)"]}]},{"name":"Research and Innovation Director (RID) office of Institute of Health, Jimma University","award":["Mega Research Fund Scheme (2022-2025)"],"award-info":[{"award-number":["Mega Research Fund Scheme (2022-2025)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11474-5","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:53:38Z","timestamp":1755654818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bacterial isolates and antibiotic resistance in critically ill sepsis patients at a tertiary hospital in Ethiopia"],"prefix":"10.1186","volume":"25","author":[{"given":"Girum Tesfaye","family":"Kiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeleke","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsah Tegene","family":"Asefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esayas Kebede","family":"Gudina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getenet","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekidim","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemeda","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"4","key":"11474_CR1","first-page":"299","volume":"66","author":"M Singer","year":"2012","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Acta Med Okayama. 2012;66(4):299\u2013305.","journal-title":"Acta Med Okayama"},{"key":"11474_CR2","unstructured":"WHO. Sepsis [Internet]. 2020 [cited 2021 Sep 17]. Available from: https:\/\/www.who.int\/news-room\/factsheets\/detail\/sepsis?__cf_chl_captcha_tk__=pmd_kulzVSlRw5lPKCgTWghJW6kI6fErTbbJP0p7HTJ297E-1631864259-0-gqNtZGzNAuWjcnBszQmR"},{"issue":"10219","key":"11474_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"18","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;18(10219):200\u201311.","journal-title":"Lancet"},{"key":"11474_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy313","author":"Y Sakr","year":"2018","unstructured":"Sakr Y, Jaschinski U, Wittebole Xavier, Szakmany T, Lipman J, \u00d1amendys-Silva SA, et al. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis. 2018. https:\/\/doi.org\/10.1093\/ofid\/ofy313.","journal-title":"Open Forum Infect Dis"},{"key":"11474_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhin.2023.11.012","volume":"144","author":"GT Kiya","year":"2024","unstructured":"Kiya GT, Mekonnen Z, Melaku T, Tegene E, Gudina EK, Cools P, et al. Prevalence and mortality rate of sepsis among adults admitted to hospitals in sub-Saharan Africa: a systematic review and meta-analysis. J Hosp Infect. 2024;144:1\u201313.","journal-title":"J Hosp Infect"},{"issue":"Fig 1","key":"11474_CR6","first-page":"117863611882508","volume":"12","author":"X Chen","year":"2019","unstructured":"Dolin HH, Papadimos TJ, Chen X, Pan ZK. Characterization of pathogenic sepsis etiologies and patient profiles: a novel approach to triage and treatment. Microbiol Insights. 2019;12(Fig 1):117863611882508.","journal-title":"Microbiol Insights"},{"issue":"1","key":"11474_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-020-00871-x","volume":"10","author":"YR Saharman","year":"2021","unstructured":"Saharman YR, Karuniawati A, Severin JA, Verbrugh HA. Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review. Antimicrob Resist Infect Control. 2021;10(1):1\u201319.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"11474_CR8","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/CCM.0000000000005662","volume":"50","author":"A Gouel-Cheron","year":"2022","unstructured":"Gouel-Cheron A, Swihart BJ, Warner S, Mathew L, Strich JR, Mancera A, et al. Epidemiology of ICU-onset bloodstream infection: prevalence, pathogens, and risk factors among 150,948 ICU patients at 85 U.S. hospitals. Crit Care Med. 2022;50(12):1725.","journal-title":"Crit Care Med"},{"issue":"2","key":"11474_CR9","first-page":"1","volume":"17","author":"K Kontopoulou","year":"2013","unstructured":"Kontopoulou K, Tsepanis K, Sgouropoulos I, Triantafyllidou A, Socratous D, Tassioudis P, et al. Risk factors associated with acinetobacter baumannii septicemia and its mortality rates in critically ill patients. Crit Care 2013 172. 2013;17(2):1\u2013200.","journal-title":"Crit Care 2013 172"},{"key":"11474_CR10","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2147\/IDR.S183283","volume":"11","author":"A Fentie","year":"2018","unstructured":"Fentie A, Wondimeneh Y, Balcha A, Amsalu A, Adankie BT. Bacterial profile, antibiotic resistance pattern and associated factors among cancer patients at university of Gondar hospital, Northwest Ethiopia. Infect Drug Resist. 2018;11:2169\u201378.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"11474_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-024-09335-8","volume":"24","author":"M Lan","year":"2024","unstructured":"Lan M, Dongmei K, Guodong S, Haifeng Y, Guofeng C, Mengting C, et al. Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia. BMC Infect Dis. 2024;24(1):1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"11474_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/sur.2020.047","volume":"21","author":"AH Stephen","year":"2020","unstructured":"Stephen AH, Montoya RLAA. Sepsis and septic shock in low- and middle-income countries. Surg Infect. 2020;21(7):571\u20138.","journal-title":"Surg Infect"},{"key":"11474_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13756-017-0208-x","volume":"6","author":"JA Ayukekbong","year":"2017","unstructured":"Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47.","journal-title":"Antimicrob Resist Infect Control"},{"key":"11474_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.21037\/jeccm.2018.11.08","volume":"2","author":"M Tosi","year":"2018","unstructured":"Tosi M, Roat E, De Biasi S, Munari E, Venturelli S, Coloretti I, et al. Multidrug resistant bacteria in critically ill patients: a step further antibiotic therapy. J Emerg Crit Care Med. 2018;2:103\u2013103.","journal-title":"J Emerg Crit Care Med"},{"issue":"3","key":"11474_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/phar.2171","volume":"39","author":"IL MJ","year":"2019","unstructured":"MJ IL, MH DAS. A multicenter, prospective, observational study to determine predictive factors for Multidrug-Resistant pneumonia in critically ill adults: the DEFINE study. Pharmacotherapy. 2019;39(3):253\u201360.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"11474_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/antibiotics12030459","volume":"12","author":"M Chakraborty","year":"2023","unstructured":"Chakraborty M, Sardar S, De R, Biswas M, Mascellino MT, Miele MC, et al. Current trends in antimicrobial resistance patterns in bacterial pathogens among adult and pediatric patients in the intensive care unit in a tertiary care hospital in Kolkata, India. Antibiotics. 2023;12(3):459.","journal-title":"Antibiotics"},{"issue":"1","key":"11474_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-017-2695-5","volume":"10","author":"P Agaba","year":"2017","unstructured":"Agaba P, Tumukunde J, Tindimwebwa JVB, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes. 2017;10(1):1\u201312.","journal-title":"BMC Res Notes"},{"issue":"5","key":"11474_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/pathogens13050411","volume":"13","author":"D Bandi\u0107 Pavlovi\u0107","year":"2024","unstructured":"Bandi\u0107 Pavlovi\u0107 D, Pospi\u0161il M, Na\u0111 M, Vrbanovi\u0107 Mijatovi\u0107 V, Luxner J, Zarfel G, et al. Multidrug-resistant bacteria in surgical intensive care units: antibiotic susceptibility and \u03b2-lactamase characterization. Pathogens. 2024;13(5):411.","journal-title":"Pathogens"},{"key":"11474_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1376513","volume":"12","author":"Q Li","year":"2024","unstructured":"Li Q, Zhou X, Yang R, Shen X, Li G, Zhang C, et al. Carbapenem-resistant Gram-negative bacteria (CR-GNB) in ICUs: resistance genes, therapeutics, and prevention \u2013 a comprehensive review. Front Public Health. 2024;12: 1376513.","journal-title":"Front Public Health"},{"key":"11474_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287453","author":"D Beshah","year":"2023","unstructured":"Beshah D, Desta AF, Woldemichael GB, Belachew EB, Derese SG, Zelelie TZ, et al. High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia. PLoS One. 2023. https:\/\/doi.org\/10.1371\/journal.pone.0287453.","journal-title":"PLoS One"},{"issue":"1","key":"11474_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-024-03485-0","volume":"24","author":"M Tilahun","year":"2024","unstructured":"Tilahun M, Sharew B, Shibabaw A. Antimicrobial resistance profile and associated factors of hospital-acquired gram-negative bacterial pathogens among hospitalized patients in Northeast Ethiopia. BMC Microbiol. 2024;24(1):1\u201317.","journal-title":"BMC Microbiol"},{"issue":"1","key":"11474_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-016-0103-x","volume":"5","author":"MA Sid Ahmed","year":"2016","unstructured":"Sid Ahmed MA, Bansal D, Acharya A, Elmi AA, Hamid JM, Sid Ahmed AM, et al. Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrob Resist Infect Control. 2016;5(1):1\u20136.","journal-title":"Antimicrob Resist Infect Control"},{"key":"11474_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2147\/IDR.S292246","volume":"14","author":"M Alebel","year":"2021","unstructured":"Alebel M, Mekonnen F, Mulu W. Extended-spectrum \u03b2-lactamase and carbapenemase producing Gram-negative bacilli infections among patients in intensive care units of Felegehiwot referral hospital: a prospective cross-sectional study. Infect Drug Resist. 2021;14:391.","journal-title":"Infect Drug Resist"},{"key":"11474_CR24","doi-asserted-by":"publisher","first-page":"1336387","DOI":"10.3389\/fmicb.2024.1336387","volume":"15","author":"M Gashaw","year":"2024","unstructured":"Gashaw M, Gudina EK, Ali S, Gabriele L, Seeholzer T, Alemu B, et al. Molecular characterization of carbapenem-resistance in Gram-negative isolates obtained from clinical samples at Jimma medical center, Ethiopia. Front Microbiol. 2024;15:1336387.","journal-title":"Front Microbiol"},{"issue":"1","key":"11474_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-025-01695-w","volume":"25","author":"M Tigabie","year":"2025","unstructured":"Tigabie M, Ayalew G, Demoze L, Tadesse K, Gashaw Y, Assefa M. Extended-spectrum beta-lactamase and carbapenemase-producing gram-negative bacteria in urinary tract infections in Ethiopia: a systematic review and meta-analysis. BMC Urol. 2025;25(1):1\u201319.","journal-title":"BMC Urol"},{"key":"11474_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08237-5","author":"E Alemayehu","year":"2023","unstructured":"Alemayehu E, Fiseha T, Gedefie A, Alemayehu Tesfaye N, Ebrahim H, Ebrahim E, et al. Prevalence of carbapenemase-producing Enterobacteriaceae from human clinical samples in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2023. https:\/\/doi.org\/10.1186\/s12879-023-08237-5.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11474_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2110-5820-1-47","volume":"1","author":"N Brusselaers","year":"2011","unstructured":"Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care. 2011;1(1):47.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"11474_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.afjem.2020.10.001","volume":"11","author":"HA Mulatu","year":"2021","unstructured":"Mulatu HA, Bayisa T, Worku Y, Lazarus JJ, Woldeyes E, Bacha D, et al. Prevalence and outcome of sepsis and septic shock in intensive care units in Addis Ababa, Ethiopia: a prospective observational study. Afr J Emerg Med. 2021;11(1):188\u201395.","journal-title":"Afr J Emerg Med"},{"key":"11474_CR29","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute. 2024."},{"key":"11474_CR30","unstructured":"AMPC ESBL DETECTION SET [Internet]. [cited 2025 Apr 14]. Available from: https:\/\/www.mast-group.com\/uk\/products\/amr\/antibiotic-resistance-detection-sets\/d68c\/"},{"key":"11474_CR31","unstructured":"MASTDISCS COMBI CARBA PLUS [Internet]. [cited 2025 Apr 14]. Available from: https:\/\/www.mast-group.com\/uk\/products\/amr\/antibiotic-resistance-detection-sets\/d73c\/"},{"issue":"1","key":"11474_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/1348-0421.12553","volume":"62","author":"Y Ohsaki","year":"2018","unstructured":"Ohsaki Y, Kubo R, Hobson J, Davies M, Osaka S, Hayashi W, et al. MASTDISCS combi carba plus, a simple method for discriminating carbapenemase-producing enterobacteriaceae, including OXA-48-type producers. Microbiol Immunol. 2018;62(1):60\u20135.","journal-title":"Microbiol Immunol"},{"issue":"7","key":"11474_CR33","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.ajic.2016.01.021","volume":"44","author":"SM Mitharwal","year":"2016","unstructured":"Mitharwal SM, Yaddanapudi S, Bhardwaj N, Gautam V, Biswal M, Yaddanapudi L. Intensive care unit-acquired infections in a tertiary care hospital: an epidemiologic survey and influence on patient outcomes. Am J Infect Control. 2016;44(7):e113-7.","journal-title":"Am J Infect Control"},{"key":"11474_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jcrc.2016.04.018","volume":"34","author":"G Iliyasu","year":"2016","unstructured":"Iliyasu G, Daiyab FM, Tiamiyu AB, Abubakar S, Habib ZG, Sarki AM, et al. Nosocomial infections and resistance pattern of common bacterial isolates in an intensive care unit of a tertiary hospital in Nigeria: a 4-year review. J Crit Care. 2016;34:116\u201320.","journal-title":"J Crit Care"},{"key":"11474_CR35","doi-asserted-by":"publisher","first-page":"6943","DOI":"10.3390\/ijerph17196943","volume":"17","author":"A Litwin","year":"2020","unstructured":"Litwin A, Fedorowicz O, Duszynska W. Characteristics of microbial factors of Healthcare-Associated infections including Multidrug-Resistant pathogens and antibiotic consumption at the university intensive care unit in Poland in the. Int J Environ Res Public Heal. 2020;17:6943.","journal-title":"Int J Environ Res Public Heal"},{"issue":"11","key":"11474_CR36","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.3390\/microorganisms9112246","volume":"9","author":"FA Wani","year":"2021","unstructured":"Wani FA, Bandy A, Alenzi MJS, Alzarea AI, Alanazi AS, Sayeed MU, et al. Resistance patterns of gram-negative bacteria recovered from clinical specimens of intensive care patients. Microorganisms. 2021;9(11):2246.","journal-title":"Microorganisms"},{"issue":"10","key":"11474_CR37","doi-asserted-by":"publisher","first-page":"e0165242","DOI":"10.1371\/journal.pone.0165242","volume":"11","author":"AA Iwuafor","year":"2016","unstructured":"Iwuafor AA, Ogunsola FT, Oladele RO, Oduyebo OO, Desalu I, Egwuatu CC, et al. Incidence, clinical outcome and risk factors of intensive care unit infections in the Lagos university teaching hospital (LUTH), Lagos, Nigeria. PLoS One. 2016;11(10):e0165242.","journal-title":"PLoS One"},{"issue":"3","key":"11474_CR38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jointm.2022.10.001","volume":"3","author":"Z Ture","year":"2023","unstructured":"Ture Z, G\u00fcner R, Alp E. Antimicrobial stewardship in the intensive care unit. J Intensive Med. 2023;3(3):244\u201353.","journal-title":"J Intensive Med"},{"key":"11474_CR39","doi-asserted-by":"crossref","unstructured":"Calvo M, Stefani S, Migliorisi G. Bacterial Infections in Intensive Care Units: Epidemiological and Microbiological Aspects. Antibiot 2024, Vol 13, Page 238. 2024;13(3):238.","DOI":"10.3390\/antibiotics13030238"},{"issue":"4","key":"11474_CR40","first-page":"288","volume":"6","author":"SG Siddique","year":"2017","unstructured":"Siddique SG, Bhalchandra MH, Wyawahare AS, Bansal VP, Mishra JK, Naik SD. Prevalence of MRSA, ESBL and carbapenemase producing isolates obtained from endotracheal and tracheal tubes secretions of ICU patient at tertiary care centre. IntJCurrMicrobiolAppSci. 2017;6(4):288\u201399.","journal-title":"IntJCurrMicrobiolAppSci"},{"issue":"6","key":"11474_CR41","doi-asserted-by":"publisher","first-page":"e0287453","DOI":"10.1371\/journal.pone.0287453","volume":"18","author":"D Beshah","year":"2023","unstructured":"Beshah D, Desta AF, Woldemichael GB, Belachew EB, Derese SG, Zelelie TZ, et al. High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia. PLoS One. 2023;18(6):e0287453.","journal-title":"PLoS One"},{"issue":"2","key":"11474_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4103\/0971-5916.195043","volume":"144","author":"R Gupta","year":"2016","unstructured":"Gupta R, Malik A, Rizvi M, Ahmed M. Presence of metallo-beta-lactamases (MBL), extended-spectrum beta-lactamase (ESBL) & AmpC positive non-fermenting Gram-negative bacilli among intensive care unit patients with special reference to molecular detection of blaCTX-M & BlaAmpC genes. Indian J Med Res. 2016;144(2):271\u20135.","journal-title":"Indian J Med Res"},{"key":"11474_CR43","doi-asserted-by":"crossref","unstructured":"Yuan L, Qin P, Qangqiang LBC. Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections. Int Urol Nephrol. 2025;57(4).","DOI":"10.1007\/s11255-025-04417-1"},{"key":"11474_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13756-019-0488-4","volume":"8","author":"DS Teklu","year":"2019","unstructured":"Teklu DS, Negeri AA, Legese MH, et al. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8:39.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"11474_CR45","first-page":"50","volume":"13","author":"S Bahrami","year":"2021","unstructured":"Bahrami S, Shafiee F, Hakamifard A, Fazeli HSR. Antimicrobial susceptibility pattern of carbapenemase-producing gram-negative nosocomial bacteria at al Zahra hospital, Isfahan, Iran. Iran J Microbiol. 2021;13(1):50\u20137.","journal-title":"Iran J Microbiol"},{"issue":"6","key":"11474_CR46","first-page":"140","volume":"9","author":"JRIV Aishwarya","year":"2021","unstructured":"Aishwarya JRIV. Prevalence and antimicrobial susceptibility pattern of carbapenemase producing Gram-Negative bacterial isolates. J Res Med Dent Sci. 2021;9(6):140\u20139.","journal-title":"J Res Med Dent Sci"},{"issue":"10","key":"11474_CR47","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.15537\/smj.2018.10.22944","volume":"39","author":"ME Ibrahim","year":"2018","unstructured":"Ibrahim ME. High antimicrobial resistant rates among Gram-negative pathogens in intensive care units: a retrospective study at a tertiary care hospital in Southwest Saudi Arabia. Saudi Med J. 2018;39(10):1035.","journal-title":"Saudi Med J"},{"issue":"1","key":"11474_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12879-017-2529-z","volume":"17","author":"GM Tran","year":"2017","unstructured":"Tran GM, Ho-Le TP, Ha DT, Tran-Nguyen CH, Nguyen TSM, Pham TTN, et al. Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam. BMC Infect Dis. 2017;17(1):429.","journal-title":"BMC Infect Dis"},{"key":"11474_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06527-4","author":"TC Dawit","year":"2021","unstructured":"Dawit TC, Mengesha RE, Ebrahim MM, Tequare MH, Abraha HE. Nosocomial sepsis and drug susceptibility pattern among patients admitted to adult intensive care unit of Ayder Comprehensive Specialized Hospital, Northern Ethiopia. BMC Infect Dis. 2021. https:\/\/doi.org\/10.1186\/s12879-021-06527-4.","journal-title":"BMC Infect Dis"},{"key":"11474_CR50","doi-asserted-by":"publisher","DOI":"10.22207\/JPAM.19.2.03","author":"K Fizza","year":"2025","unstructured":"Fizza K, Christy P, Azza E, Abid M, Osamah TK. Spectrum of isolates and antimicrobial susceptibility pattern from blood cultures in tertiary care hospital, Riyadh. J Pure Appl Microbiol. 2025. https:\/\/doi.org\/10.22207\/JPAM.19.2.03.","journal-title":"J Pure Appl Microbiol"},{"issue":"4","key":"11474_CR51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijantimicag.2011.05.013","volume":"38","author":"H Hanberger","year":"2011","unstructured":"Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, et al. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents. 2011;38(4):331\u20135.","journal-title":"Int J Antimicrob Agents"},{"issue":"19","key":"11474_CR52","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1001\/archinte.162.19.2229","volume":"162","author":"SI Blot","year":"2002","unstructured":"Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med. 2002;162(19):2229\u201335.","journal-title":"Arch Intern Med"},{"key":"11474_CR53","doi-asserted-by":"crossref","unstructured":"Marwan J, Alwazzeh J, Algazaq FA, Al-Salem F, Alabkari SM, Alwarthan M, Alhajri BM, AlShehail. Amani Alnimr, Ahmad Wajeeh Alrefaai FHA& FAA. Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by Multidrug-resistant Acinetobacter baumannii in critically ill patients. 25, 416 (2025). BMC Infect Dis. 2025;25(416).","DOI":"10.1186\/s12879-025-10781-1"},{"key":"11474_CR54","doi-asserted-by":"crossref","unstructured":"SS. Multidrug resistance in critically ill patients: an unresolved issue. Microorganisms. 2023;11(4):946.","DOI":"10.3390\/microorganisms11040946"},{"issue":"12","key":"11474_CR55","doi-asserted-by":"publisher","first-page":"787","DOI":"10.12998\/wjcc.v2.i12.787","volume":"2","author":"MF L","year":"2014","unstructured":"L MF. Antimicrobial resistance in acinetobacter baumannii: from bench to bedside. WJCC. 2014;2(12):787.","journal-title":"WJCC"},{"issue":"3","key":"11474_CR56","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/ijerph19031039","volume":"19","author":"NF Fern\u00e1ndez-Mart\u00ednez","year":"2022","unstructured":"Fern\u00e1ndez-Mart\u00ednez NF, C\u00e1rcel-Fern\u00e1ndez S, De la Fuente-Martos C, Ruiz-Montero R, Guzm\u00e1n-Herrador BR, Le\u00f3n-L\u00f3pez R, G\u00f3mez FJ, Guzm\u00e1n-Puche J, Mart\u00ednez-Mart\u00ednez. L S-LI. Risk factors for Multidrug-Resistant Gram-Negative bacteria carriage upon admission to the intensive care unit. Int J Env Res Public Heal. 2022;19(3):1039.","journal-title":"Int J Env Res Public Heal"},{"issue":"Suppl 1","key":"11474_CR57","doi-asserted-by":"publisher","first-page":"A882","DOI":"10.1186\/2197-425X-3-S1-A882","volume":"3","author":"CS Scheer","year":"2015","unstructured":"Scheer CS, Fuchs C, Rehberg S, Bast J, Vollmer M, Balau V, et al. Incidence of pathogen detection in blood cultures of severe sepsis and septic shock patients is higher, if blood cultures were drawn before anti-infective therapy. Intensive Care Med Exp. 2015;3(Suppl 1):A882.","journal-title":"Intensive Care Med Exp"},{"issue":"8","key":"11474_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.7326\/M19-1696","volume":"171","author":"MP Cheng","year":"2019","unstructured":"Cheng MP, Stenstrom R, Paquette K, Stabler SN, Akhter M, Davidson AC, et al. Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study. Ann Intern Med. 2019;171(8):547\u201354.","journal-title":"Ann Intern Med"},{"issue":"3","key":"11474_CR59","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cmi.2018.05.016","volume":"25","author":"CS Scheer","year":"2019","unstructured":"Scheer CS, Fuchs C, Gr\u00fcndling M, Vollmer M, Bast J, Bohnert JA, et al. Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study. Clin Microbiol Infect. 2019;25(3):326\u201331.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"11474_CR60","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"2","key":"11474_CR61","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s15010-023-02105-9","volume":"52","author":"L Zornitzki","year":"2024","unstructured":"Zornitzki L, Anuk L, Frydman S, Morag-Koren N, Zahler D, Freund O, et al. Rate and predictors of blood culture positivity after antibiotic administration: a prospective single-center study. Infection. 2024;52(2):483\u201390.","journal-title":"Infection"},{"issue":"5","key":"11474_CR62","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz179","volume":"6","author":"KH Rand","year":"2019","unstructured":"Rand KH, Beal SG, Rivera K, Allen B, Payton T, Lipori GP. Hourly effect of pretreatment with IV antibiotics on blood culture positivity rate in emergency department patients. Open Forum Infect Dis. 2019;6(5): ofz179.","journal-title":"Open Forum Infect Dis"},{"key":"11474_CR63","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.2147\/IDR.S334161","volume":"14","author":"L Yang","year":"2021","unstructured":"Yang L, Lin Y, Wang J, Song J, Wei B, Zhang X, et al. Comparison of clinical characteristics and outcomes between positive and negative blood culture septic patients: A retrospective cohort study. Infect Drug Resist. 2021;144191\u2013205","journal-title":"Infect Drug Resist"},{"issue":"1","key":"11474_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/08998280.2015.11929172","volume":"28","author":"D Armstrong-Briley","year":"2015","unstructured":"Armstrong-Briley D, Hozhabri NST, Armstrong K, Puthottile J, Benavides R, Beal S. Comparison of length of stay and outcomes of patients with positive versus negative blood culture results. Baylor Univ Med Cent Proc. 2015;28(1):10\u20133.","journal-title":"Baylor Univ Med Cent Proc"},{"issue":"1","key":"11474_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-021-03592-8","volume":"25","author":"Y Li","year":"2021","unstructured":"Li Y, Guo J, Yang H, Li H, Shen Y, Zhang D. Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2021;25(1):1\u20139.","journal-title":"Crit Care"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11474-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11474-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11474-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:19:00Z","timestamp":1757438340000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11474-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11474"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11474-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Institutional Review Board (IRB) of Jimma University Institute of Health (reference number: JUIH\/IRB\/309\/23). Prior to the commencement of the study, written informed consent from adults aged 18 and above, and assent from children aged 12 and above was obtained. Informed consent was obtained from legal guardians and caregivers for the minors and impaired consciousness participants. Participants were thoroughly briefed on the study\u2019s objectives and procedures before the study. Involvement in the study was entirely voluntary. All collected information was kept confidential and used exclusively for this research. Any positive results were immediately communicated to the attending physician to ensure proper and timely treatment for the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1046"}}